EASD 2020: GIP Infusion Appears to Attenuate Postprandial Glucose Excursions in Type 1 Diabetes
The therapy could potentially be used as add-on therapy in diabetes.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.